ReP USP - Resultado da busca

Artigo de periodico
Cardiovascular disease onset in old people with severe hypercholesterolemia (2023)
Coutinho, Elaine R; Miname, Marcio H; Rocha, Viviane Z; Bittencourt, Marcio S; Jannes, Cinthia E; Krieger, Jose Eduardo ; Pereira, Alexandre C; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, FATORES DE RISCO, ARTERIOSCLEROSE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, v. 365, p. 9-14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52911. Acesso em: 03 jun. 2024.
APA
Coutinho, E. R., Miname, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Krieger, J. E., et al. (2023). Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, 365, 9-14. doi:10.1016/j.atherosclerosis.2022.12.007
NLM
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Vancouver
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Artigo de periodico
Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk (2021)
Ma, Feng; Darabi, Maryam; Lhomme, Marie; Tubeuf, Emilie; Canicio, Aurelie; Brerault, Jean; Medadje, Narcisse; Rached, Fabiana; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS HDL, COLESTEROL, FATORES DE RISCO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MA, Feng et al. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, v. 324, p. 01-08, 2021Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53856. Acesso em: 03 jun. 2024.
APA
Ma, F., Darabi, M., Lhomme, M., Tubeuf, E., Canicio, A., Brerault, J., et al. (2021). Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, 324, 01-08. doi:10.1016/j.atherosclerosis.2021.03.002
NLM
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Vancouver
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 jun. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Artigo de periodico
Familial hypercholesterolemia and cardiovascular disease in older individuals (2021)
Coutinho, Elaine R; Minami, Marcio H; Rocha, Viviane Z; Bittencourt, Márcio Sommer ; Jannes, Cinthia E; Tada, Mauricio T; Lima, Isabella R; Salgado Filho, Wilson; Chacra, Ana P; Pereira, Alexandre C; Krieger, Jose Eduardo ; Santos, Raul D
Source: Atherosclerosis. Unidades: HU, FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, IDOSOS, ENVELHECIMENTO, ARTERIOSCLEROSE, COLESTEROL, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, v. 318, p. 32-37, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.12.012. Acesso em: 03 jun. 2024.
APA
Coutinho, E. R., Minami, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Tada, M. T., et al. (2021). Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, 318, 32-37. doi:10.1016/j.atherosclerosis.2020.12.012
NLM
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Vancouver
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Artigo de periodico
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels (2020)
Zheng, Kang H; Kaiser, Yannick; Olden, Casper C. van; Santos Filho, Raul Dias dos ; Dasseux, Jean-Louis; Genest, Jacques; Gaudet, Daniel; Westerink, Jan; Verberne, Hein J
Source: Atherosclerosis. Unidade: FM
Subjects: APOLIPOPROTEÍNAS, COLESTEROL, LIPOPROTEÍNAS HDL, MEIA IDADE, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.004. Acesso em: 03 jun. 2024.
APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004
NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Artigo de periodico
Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study (2020)
Janovsky, Carolina Castro Porto Silva; Generoso, Giuliano; Goulart, Alessandra C; Santos Filho, Raul Dias dos ; Blaha, Michael J; Jones, Steven; Toth, Peter P.; Lotufo, Paulo Andrade ; Bittencourt, Marcio Sommer; Benseñor, Isabela Judith Martins
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, HIPERTIREOIDISMO, DIAGNÓSTICO, EPIDEMIOLOGIA, MEIA IDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANOVSKY, Carolina Castro Porto Silva et al. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, v. 312, p. 60-65, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.021. Acesso em: 03 jun. 2024.
APA
Janovsky, C. C. P. S., Generoso, G., Goulart, A. C., Santos Filho, R. D. dos, Blaha, M. J., Jones, S., et al. (2020). Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, 312, 60-65. doi:10.1016/j.atherosclerosis.2020.08.021
NLM
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021
Vancouver
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021
Artigo de periodico-carta/editorial
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? (2020)
Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: ARTERIOSCLEROSE, CALCIFICAÇÃO FISIOLÓGICA, VASOS CORONÁRIOS, CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels?. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.12.019. Acesso em: 03 jun. 2024. , 2020
APA
Santos Filho, R. D. dos. (2020). Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.12.019
NLM
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Vancouver
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Artigo de periodico
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
Reeskamp, Laurens F; Kastelein, John J. P; Moriarty, Patrick M; Duell, P. Barton; Catapano, Alberico L; Santos Filho, Raul Dias dos; Ballantyne, Christie M
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, OLIGONUCLEOTÍDEOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REESKAMP, Laurens F et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 280, p. 109-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.11.017. Acesso em: 03 jun. 2024.
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Artigo de periodico
In memoriam: Dr. Akira Yamamoto 1932-2019 (2019)
Matsuzawa, Yuji; Yamashita, Shizuya; Santos Filho, Raul Dias dos; Libby, Peter
Source: Atherosclerosis. Unidade: FM
Subjects: ESTATINAS, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUZAWA, Yuji et al. In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, v. 283, p. 120-120, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.01.028. Acesso em: 03 jun. 2024.
APA
Matsuzawa, Y., Yamashita, S., Santos Filho, R. D. dos, & Libby, P. (2019). In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, 283, 120-120. doi:10.1016/j.atherosclerosis.2019.01.028
NLM
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Vancouver
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Artigo de periodico
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps (2019)
Santos Filho, Raul Dias dos; Valenti, Luca; Romeo, Stefano
Source: Atherosclerosis. Unidade: FM
Subjects: FÍGADO GORDUROSO, HEPATOPATIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos e VALENTI, Luca e ROMEO, Stefano. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, v. 282, p. 110-120, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.01.029. Acesso em: 03 jun. 2024.
APA
Santos Filho, R. D. dos, Valenti, L., & Romeo, S. (2019). Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, 282, 110-120. doi:10.1016/j.atherosclerosis.2019.01.029
NLM
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.029
Vancouver
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.029
Artigo de periodico
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia (2019)
Isla, Leopoldo Perez de; Ray, Kausik K.; Watts, Gerald F.; Santos Filho, Raul Dias dos ; Alonso, Rodrigo; Muniz-grijalvo, Ovidio; Diaz-diaz, Jose Luis; Badimon, Lina; Catapano, Alberico L; Mata, Pedro
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, AVALIAÇÃO DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLA, Leopoldo Perez de et al. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 286, p. 40-45, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.05.003. Acesso em: 03 jun. 2024.
APA
Isla, L. P. de, Ray, K. K., Watts, G. F., Santos Filho, R. D. dos, Alonso, R., Muniz-grijalvo, O., et al. (2019). Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, 286, 40-45. doi:10.1016/j.atherosclerosis.2019.05.003
NLM
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003
Vancouver
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003
Artigo de periodico-carta/editorial
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH (2019)
Santos Filho, Raul Dias dos; Watts, Gerald F
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE, CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos e WATTS, Gerald F. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.12.013. Acesso em: 03 jun. 2024. , 2019
APA
Santos Filho, R. D. dos, & Watts, G. F. (2019). Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2018.12.013
NLM
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.12.013
Vancouver
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.12.013
Artigo de periodico
Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults (2018)
Fernandes, Romulo Araujo; Santos, Raul D
Source: Atherosclerosis. Unidade: FM
Subjects: ESTUDOS LONGITUDINAIS, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, ÍNDICE DE MASSA CORPORAL, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Romulo Araujo e SANTOS, Raul D. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, v. 273, p. 131-135, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.02.011. Acesso em: 03 jun. 2024.
APA
Fernandes, R. A., & Santos, R. D. (2018). Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, 273, 131-135. doi:10.1016/j.atherosclerosis.2018.02.011
NLM
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.02.011
Vancouver
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.02.011
Trabalho de evento-resumo periodico
Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions (2018)
Tavoni, Thauany Martins; Vinagre, Carmen Guilherme Christiano de Matos; Freitas, Fatima Rodrigues; Mesquita, Carlos Henrique de; Vinagre, Juliana Christiano de Matos; Mariani, A. C; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVONI, Thauany Martins et al. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 03 jun. 2024. , 2018
APA
Tavoni, T. M., Vinagre, C. G. C. de M., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C. de M., Mariani, A. C., et al. (2018). Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 jun. 03 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 jun. 03 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 03 jun. 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 jun. 03 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 jun. 03 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Artigo de periodico
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice (2018)
Pang, Jing; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DIAGNÓSTICO PRECOCE, ACONSELHAMENTO, MODO DE VIDA, SUL-AFRICANOS, AUSTRALIANOS, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANG, Jing e SANTOS FILHO, Raul Dias dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, v. 277, p. 470-476, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.06.822. Acesso em: 03 jun. 2024.
APA
Pang, J., & Santos Filho, R. D. dos. (2018). Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, 277, 470-476. doi:10.1016/j.atherosclerosis.2018.06.822
NLM
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.822
Vancouver
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.822
Artigo de periodico
Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil (2018)
Souto, Ana Cristina; Krieger, José Eduardo; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, QUALIDADE DE VIDA, TRIAGEM, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUTO, Ana Cristina e KRIEGER, José Eduardo e SANTOS FILHO, Raul Dias dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, v. 277, p. 464-469, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.05.036. Acesso em: 03 jun. 2024.
APA
Souto, A. C., Krieger, J. E., & Santos Filho, R. D. dos. (2018). Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, 277, 464-469. doi:10.1016/j.atherosclerosis.2018.05.036
NLM
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.05.036
Vancouver
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.05.036
Artigo de periodico
Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil (2018)
Harada, Paulo H; Bensenor, Isabela M; Santos Filho, Raul Dias; Lotufo, Paulo Andrade; Miname, Márcio H
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, PREVALÊNCIA, ESTUDOS LONGITUDINAIS, GRUPOS ÉTNICOS, FATORES SEXUAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARADA, Paulo H et al. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil. Atherosclerosis, v. 277, p. 273-277, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.08.021. Acesso em: 03 jun. 2024.
APA
Harada, P. H., Bensenor, I. M., Santos Filho, R. D., Lotufo, P. A., & Miname, M. H. (2018). Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil. Atherosclerosis, 277, 273-277. doi:10.1016/j.atherosclerosis.2018.08.021
NLM
Harada PH, Bensenor IM, Santos Filho RD, Lotufo PA, Miname MH. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil [Internet]. Atherosclerosis. 2018 ; 277 273-277.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.021
Vancouver
Harada PH, Bensenor IM, Santos Filho RD, Lotufo PA, Miname MH. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil [Internet]. Atherosclerosis. 2018 ; 277 273-277.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.021
Artigo de periodico
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia (2018)
Hagger, Martin S; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, ADESÃO À MEDICAÇÃO, SENSO COMUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAGGER, Martin S e SANTOS FILHO, Raul Dias dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, v. 277, p. 493-501, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.06.010. Acesso em: 03 jun. 2024.
APA
Hagger, M. S., & Santos Filho, R. D. dos. (2018). Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, 277, 493-501. doi:10.1016/j.atherosclerosis.2018.06.010
NLM
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010
Vancouver
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010
Artigo de periodico
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2018)
Vallejo-vaz, Antonio J; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, COOPERAÇÃO INTERNACIONAL, MÉTODOS EPIDEMIOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALLEJO-VAZ, Antonio J e SANTOS FILHO, Raul Dias dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, v. 277, p. 234-255, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.08.051. Acesso em: 03 jun. 2024.
APA
Vallejo-vaz, A. J., & Santos Filho, R. D. dos. (2018). Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, 277, 234-255. doi:10.1016/j.atherosclerosis.2018.08.051
NLM
Vallejo-vaz AJ, Santos Filho RD dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) [Internet]. Atherosclerosis. 2018 ; 277 234-255.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.051
Vancouver
Vallejo-vaz AJ, Santos Filho RD dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) [Internet]. Atherosclerosis. 2018 ; 277 234-255.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.051
Trabalho de evento-resumo periodico
Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model (2018)
Guido, Maria Carolina; Meneghini, Bianca Correa; Tavares, Elaine Rufo; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 03 jun. 2024. , 2018
APA
Guido, M. C., Meneghini, B. C., Tavares, E. R., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 jun. 03 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Guido MC, Meneghini BC, Tavares ER, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 275 e49 res. SAG19.5.[citado 2024 jun. 03 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation